A detailed history of ETF Managers Group, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, ETF Managers Group, LLC holds 20,931 shares of ZLAB stock, worth $562,834. This represents 0.03% of its overall portfolio holdings.

Number of Shares
20,931
Holding current value
$562,834
% of portfolio
0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$30.21 - $48.1 $632,325 - $1.01 Million
20,931 New
20,931 $696,000
Q3 2022

Nov 14, 2022

SELL
$34.2 - $51.69 $331,158 - $500,514
-9,683 Reduced 31.2%
21,353 $730,000
Q2 2022

Aug 15, 2022

SELL
$23.14 - $49.68 $10,459 - $22,455
-452 Reduced 1.44%
31,036 $1.07 Million
Q1 2022

May 13, 2022

BUY
$27.77 - $64.4 $138,322 - $320,776
4,981 Added 18.79%
31,488 $1.43 Million
Q4 2021

Feb 14, 2022

BUY
$54.9 - $105.21 $397,805 - $762,351
7,246 Added 37.62%
26,507 $1.77 Million
Q3 2021

Nov 15, 2021

BUY
$105.0 - $178.37 $736,785 - $1.25 Million
7,017 Added 57.31%
19,261 $2.06 Million
Q2 2021

Aug 16, 2021

SELL
$125.11 - $180.0 $509,322 - $732,780
-4,071 Reduced 24.95%
12,244 $2.18 Million
Q1 2021

May 17, 2021

SELL
$126.27 - $191.71 $564,679 - $857,327
-4,472 Reduced 21.51%
16,315 $2.11 Million
Q4 2020

Feb 16, 2021

SELL
$81.94 - $135.34 $447,392 - $738,956
-5,460 Reduced 20.8%
20,787 $2.79 Million
Q3 2020

Nov 16, 2020

BUY
$73.3 - $89.48 $1.16 Million - $1.42 Million
15,882 Added 153.23%
26,247 $2.17 Million
Q2 2020

Aug 14, 2020

BUY
$48.82 - $82.53 $506,019 - $855,423
10,365 New
10,365 $855,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.63B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.